Literature DB >> 29930863

Emergence of third-generation cephalosporin-resistant Enterobacteriacae in a Japanese critical care setting.

Hideharu Hagiya1,2, Tomoko Murase3, Masato Suzuki4, Fumio Otsuka1, Keigo Shibayama4.   

Abstract

AIM: Extended-spectrum beta-lactamases and AmpC beta-lactamases give resistance to Enterobacteriaceae against cephalosporins, which are important drugs in various clinical settings. Within 5 days, a total of eight strains of Citrobacter freundii and two strains of Escherichia coli, all of which were resistant to third-generation cephalosporins, were isolated from six different patients in a critical care center. We carried out epidemiological and genetic studies to confirm the situation to be an outbreak by a single strain or a beta-lactamase-producing gene.
METHODS: A review of patients' clinical data, pulsed-field gel electrophoresis epidemiological study against the strains, and polymerase chain reaction analysis for the detection of extended-spectrum beta-lactamase genes (TEM, SHV, CTX-M-1, CTX-M-2, and CTX-M-9) and multiplex polymerase chain reaction analysis for plasmid-mediated AmpC-beta-lactamase genes were carried out.
RESULTS: Pulsed-field gel electrophoresis showed none of the subjects were genetically identical organisms. However, all strains possessed either extended-spectrum beta-lactamases (TEM, CTX-M-2, and CTX-M-9) or AmpC-beta-lactamases. One patient carried both extended-spectrum beta-lactamase- and AmpC- beta-lactamase-producing organisms.
CONCLUSION: This study revealed that various types of easily transmittable drug resistance genes exist in the critical care setting concurrently. This case was not an outbreak of such strains, but the present situation might indicate a more serious condition than a mere outbreak of a single resistant strain. Enterobacteriaceae that possess extended-spectrum beta-lactamases or AmpC-beta-lactamases are increasingly common in many medical institutions in Japan, and constitutive monitoring of drug-resistant organisms and proper contact precautions are essential to prevent possible outbreaks.

Entities:  

Keywords:  AmpC beta‐lactamases (AmpC‐BLs); Citrobacter freundii; extended‐spectrum beta‐lactamases (ESBLs); intensive care unit (ICU); outbreak

Year:  2014        PMID: 29930863      PMCID: PMC5997195          DOI: 10.1002/ams2.64

Source DB:  PubMed          Journal:  Acute Med Surg        ISSN: 2052-8817


  6 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  A small outbreak of third generation cephem-resistant Citrobacter freundii infection on a surgical ward.

Authors:  Toshi Nada; Hisashi Baba; Kumiko Kawamura; Teruko Ohkura; Keizo Torii; Michio Ohta
Journal:  Jpn J Infect Dis       Date:  2004-08       Impact factor: 1.362

3.  PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan.

Authors:  Naohiro Shibata; Hiroshi Kurokawa; Yohei Doi; Tetsuya Yagi; Kunikazu Yamane; Jun-ichi Wachino; Satowa Suzuki; Kouji Kimura; Satoshi Ishikawa; Haru Kato; Yoshiyuki Ozawa; Keigo Shibayama; Kumiko Kai; Toshifumi Konda; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Minor outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in an intensive care unit due to a contaminated sink.

Authors:  G Starlander; Å Melhus
Journal:  J Hosp Infect       Date:  2012-08-04       Impact factor: 3.926

5.  Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit.

Authors:  Adriana Manzur; Fe Tubau; Miquel Pujol; Laura Calatayud; Maria Angeles Dominguez; Carmen Peña; Mercedes Sora; Francesc Gudiol; Javier Ariza
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

6.  Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation.

Authors:  Sarah Tschudin-Sutter; Reno Frei; Marc Dangel; Anne Stranden; Andreas F Widmer
Journal:  Clin Infect Dis       Date:  2012-09-05       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.